S1PR3 and non-small cell lung carcinoma: The research here reported the accumulation of SPHK1 in NSCLC with the potential role in cell cycle regulation, functionally through the activation of the downstream effector PBX1, and PBX1 in turn directly promoted the expression of S1PR3, thus activating the sphingolipid metabolic circuit.